AFP and hepatocellular carcinoma: Univariate analysis showed that the type of antiviral therapy (IFN treatment or IFN-free DAA therapy), albumin, PT, AST, AFP at completion of antiviral therapy, duration from last HCC treatment to starting antiviral therapy, number of past treatments for HCC, clinical stage of HCC, and SVR status were significant factors.